Dr. Karen L. Bell, MD

Dr. Bell practices at NewYork-Presbyterian Westchester in Bronxville, New York.

Dr. Bell's NPI, 1164450318, was assigned on June 28, 2006. Dr. Bell graduated from Perelman School of Medicine - Philadelphia in 1984. Dr. Bell's New York license number on file is 165359-1.

Dr. Bell's primary practice is NewYork-Presbyterian Westchester, at 55 Palmer Ave, Bronxville, NY 10708. The practice phone is (914) 787-5008.

Dr. Bell's primary practice is NewYork-Presbyterian Westchester in Bronxville, New York. Dr. Bell is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Bell to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bell practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bell's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Bell's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists alzheimer's disease and non-alzheimer's dementia (chronic) among the conditions Dr. Bell treats.

CMS data shows 725 Medicare services from Dr. Bell across 5 procedure codes in 2024, for 367 Medicare patients. Medicare paid $61,537 for them. Every service was in an office.

CMS counts 367 Medicare patients who saw Dr. Bell in 2024. The largest group is 75 to 84, with 189 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bell's median patient age at 77, with 45% women.

In 2024, Dr. Bell wrote 1,121 Medicare Part D claims for 280 patients. 98% of them were for generic drugs. CMS names the drug for 1,092 of them, across 12 drugs with 11 or more claims each, at $56,414 in total drug cost. In 2023, CMS named 1,210 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bell for performance year 2024, reported through an alternative payment model (APM). Dr. Bell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bell as offering telehealth.

Dmand AI links 143 papers to Dr. Bell, published from 2001 to 2025. 2015 was the busiest year, with 5. The most frequent topics are Alzheimer Disease, Neuropsychological Tests and Dementia. Dr. Bell has published most often in Neurology. Dr. Bell's most frequent co-authors are Karen S. Marder, MD, Richard Mayeux, MD and Davangere P. Devanand.

Dmand AI links Dr. Bell to 3 clinical trials. Conditions studied include Anosmia, Cognition Disorders and Lewy Body Disease. Open Payments lists research payments to Dr. Bell that name 1 trial.

CMS Open Payments shows 25 general payments to Dr. Bell from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Eli Lilly and Company paid the most, $17,500. It also lists 1 research payment totaling $697 in 2022, naming 1 clinical trial.

Dr. Bell graduated from Perelman School of Medicine - Philadelphia in 1984. Dr. Bell is a member of AAN.

Dr. Bell is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.